Abstract 5097: PEDF inhibits bone metastases formation, prolongs survival and enhances the antitumor efficacy of low-dose chemotherapy in castration-refractory prostate cancer.
Year: 2013
Type: conference-abstract
Source: Cancer Research
Authors: Thomas Nelius, Jennifer Hirsch, Stephanie Filleur
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2071905242
